phenylhydrazine has been researched along with sirolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babu, W; Beneduce, E; Chiabrando, D; De Falco, L; De Franceschi, L; Federti, E; Ghaffari, S; Iolascon, A; Matte, A; Mbiandjeu, S; Menon, V; Mohandas, N; Petrillo, S; Siciliano, A; Tolosano, E | 1 |
1 other study(ies) available for phenylhydrazine and sirolimus
Article | Year |
---|---|
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis.
Topics: Animals; Autophagy; Doxorubicin; Erythroblasts; Erythropoiesis; Female; Janus Kinase 2; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phenylhydrazines; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-fyn; Reactive Oxygen Species; Receptors, Erythropoietin; Signal Transduction; Sirolimus; STAT5 Transcription Factor; TOR Serine-Threonine Kinases | 2019 |